Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05631405

Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)

Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
7 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasonePatients treated with dexamethasone
DRUGPlaceboPatients treated with placebo

Timeline

Start date
2022-10-16
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2022-11-30
Last updated
2025-08-07

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT05631405. Inclusion in this directory is not an endorsement.